John G T, Chandy M, Thomas P P, Shastry J C, Jacob C K
Department of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India.
Natl Med J India. 1993 May-Jun;6(3):108-10.
Patients with chronic renal failure receive iron orally and parenterally which can lead to iron overload. However, iron deficiency is common among Indians and it is not known whether the Indian dialysis and transplant patient runs a similar risk of iron overload. The iron status is best quantified by measuring serum ferritin levels when there is no intercurrent inflammatory process. We used this method to assess the iron stores in a random sample of the Indian population on our dialysis and transplantation programme.
Serum ferritin assay was done using ELISA on samples obtained from 24 patients at entry to dialysis, before renal transplant surgery and 3 to 6 months following the surgery. All patients received 120 mg of elemental iron orally and third party transfusions according to a fixed protocol.
None of the patients had iron deficiency despite low haemoglobin values. Fifteen patients at entry, 12 out of 16 pre-transplant and 10 out of 17 post-transplant patients had evidence of iron overload. Three patients developed iron overload during the period of observation and 6 of the 10 who entered the programme with evidence of iron overload continued to have iron overload.
Indian patients with chronic renal failure have evidence of iron overload similar to those in developed countries. Oral iron supplements in Indian patients are therefore unnecessary.
慢性肾衰竭患者通过口服和胃肠外途径补充铁剂,这可能导致铁过载。然而,缺铁在印度人群中很常见,目前尚不清楚印度透析和移植患者是否存在类似的铁过载风险。在没有并发炎症过程的情况下,通过测量血清铁蛋白水平能最好地量化铁状态。我们使用这种方法对接受透析和移植治疗的印度人群随机样本的铁储备进行了评估。
采用酶联免疫吸附测定法(ELISA)对24例患者透析开始时、肾移植手术前以及术后3至6个月采集的样本进行血清铁蛋白检测。所有患者均按照固定方案口服120毫克元素铁并接受第三方输血。
尽管血红蛋白值较低,但没有患者存在缺铁情况。透析开始时15例患者、移植前16例中的12例以及移植后17例中的10例有铁过载证据。3例患者在观察期内出现铁过载,10例入院时有铁过载证据的患者中有6例持续存在铁过载。
印度慢性肾衰竭患者存在与发达国家患者类似的铁过载证据。因此,印度患者无需口服铁补充剂。